(Q37991125)

26 August 2017

title

Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients (English)

1 reference

26 August 2017

Lauren M Hynicka

1

1 reference

26 August 2017

Christopher R Ensor

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

6 March 2012

1 reference

Annals of Pharmacotherapy

26 August 2017

published in

1 reference

26 August 2017

volume

46

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

558-566

1 reference

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

26 August 2017

cites work

1 reference

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

21 January 2018

1 reference

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

21 January 2018

1 reference

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin

21 January 2018

1 reference

Respiratory syncytial virus infection following hematopoietic stem cell transplantation

21 January 2018

1 reference

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

21 January 2018

1 reference

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

Respiratory Syncytial Virus Infections in Pediatric Liver Transplant Recipients

21 January 2018

1 reference

Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin

21 January 2018

1 reference

Respiratory syncytial virus pneumonia in a cardiac transplant recipient

21 January 2018

1 reference

Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab

21 January 2018

1 reference

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

21 January 2018

1 reference

Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation

21 January 2018

1 reference

Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity

21 January 2018

1 reference

Pharmacologic advances in the treatment and prevention of respiratory syncytial virus

21 January 2018

1 reference

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

21 January 2018

1 reference

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

Inhaled ribavirin therapy in adult respiratory syncytial virus-induced acute respiratory distress syndrome

21 January 2018

1 reference

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.

21 January 2018

1 reference

Safety issues related to the administration of ribavirin

21 January 2018

1 reference

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

21 January 2018

1 reference

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline

21 January 2018

1 reference

Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience

21 January 2018

1 reference

A single-season prospective study of respiratory viral infections in lung transplant recipients

21 January 2018

1 reference

Community respiratory viral infection in adult lung transplant recipients

21 January 2018

1 reference

Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection

21 January 2018

1 reference

Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients

21 January 2018

1 reference

Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

21 January 2018

1 reference

Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome

21 January 2018

1 reference

An outbreak of respiratory syncytial virus in a bone marrow transplant center

21 January 2018

1 reference

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

21 January 2018

1 reference

Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.

21 January 2018

1 reference

Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin

21 January 2018

1 reference

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants

21 January 2018

1 reference

21 January 2018

1 reference

Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model

21 January 2018

1 reference

Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.

21 January 2018

1 reference

Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats

21 January 2018

1 reference

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Low mortality rates related to respiratory virus infections after bone marrow transplantation

21 January 2018

1 reference

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

21 January 2018

1 reference

Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience

21 January 2018

1 reference

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

21 January 2018

1 reference

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.

21 January 2018

1 reference

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

21 January 2018

1 reference

Pharmacotherapy of respiratory syncytial virus infection

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1Q553

1 reference

26 August 2017

1 reference